VANCOUVER, BRITISH COLUMBIA--(Marketwire - May 13, 2008) - ALDA Pharmaceuticals Corp. (TSX VENTURE:APH) ("ALDA") announces that it has received positive results from BioScience Laboratories, Inc. for the T36® formulation which was tested against two species of fungi responsible for athlete's foot, Trichophyton mentagrophytes and Trichophyton rubrum. T36® achieved a complete kill of both organisms within 5 minutes, the shortest time required by the FDA.
